AI-generated summary
The authors systematically reviewed and meta-analyzed randomized controlled trials of photobiomodulation therapy in adults with temporomandibular disorders, examining how intensity, frequency and duration related to pain and jaw function. They report that pain was significantly reduced at the third assessment, and that pain-free opening and assisted opening improved. Reported optimal parameters included wavelengths of 951 to 1070 nm, output power below 100 mW, and three to four sessions per week over more than 10 weeks.
- Studies included
- 40
- Who or what was studied
- Adults with temporomandibular disorders treated with photobiomodulation therapy in randomized controlled trials
- Wavelengths
- 951, 1070 nm
- Limits stated in the abstract
- unclear
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 951-1070 nm
- Power
- 100 mW
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Meta-analysis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.